Orphazyme Statistics

Total Valuation

Orphazyme has a market cap or net worth of DKK 49.64 million. The enterprise value is 31.88 million.

Market Cap	49.64M
Enterprise Value	31.88M

Important Dates

The next estimated earnings date is Wednesday, November 20, 2024.

Earnings Date	Nov 20, 2024
Ex-Dividend Date	n/a

Share Statistics

Orphazyme has 41,712 shares outstanding. The number of shares has decreased by -0.02% in one year.

Shares Outstanding	41,712
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	+0.46%
Owned by Insiders (%)	40.73%
Owned by Institutions (%)	13.36%
Float	16,816

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.61
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.79
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	17.29
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.14

Current Ratio	10.14
Quick Ratio	10.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.77% and return on invested capital (ROIC) is 5.13%.

Return on Equity (ROE)	-50.77%
Return on Assets (ROA)	4.27%
Return on Capital (ROIC)	5.13%
Revenue Per Employee	n/a
Profits Per Employee	-11.42M
Employee Count	1
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.34% in the last 52 weeks. The beta is 0.08, so Orphazyme's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	+24.34%
50-Day Moving Average	885.69
200-Day Moving Average	1,051.32
Relative Strength Index (RSI)	74.66
Average Volume (20 Days)	87

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	1.84M
Pretax Income	-11.42M
Net Income	-11.42M
EBITDA	n/a
EBIT	1.84M
Earnings Per Share (EPS)	-323.16

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	17.75M
Total Debt	n/a
Net Cash	17.75M
Net Cash Per Share	425.63
Equity (Book Value)	16.09M
Book Value Per Share	455.62
Working Capital	16.09M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.19M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Orphazyme does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.02%
Shareholder Yield	0.02%
Earnings Yield	-27.16%
FCF Yield	n/a

Stock Splits

The last stock split was on December 6, 2023. It was a reverse split with a ratio of 0.001.

Last Split Date	Dec 6, 2023
Split Type	Reverse
Split Ratio	0.001

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a